Last Updated: August 2, 2026

Intl Isotopes Company Profile

✉ Email this page to a colleague

What is the competitive landscape for INTL ISOTOPES

INTL ISOTOPES has one approved drug.

Summary for Intl Isotopes

US Patents:	0
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Intl Isotopes

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Intl Isotopes	SODIUM IODIDE I 131	sodium iodide i-131	SOLUTION;ORAL	209166-001	Feb 5, 2020	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

International Isotopes Market Position, Patent Strength, and Competitive Strategy (Competitive Landscape Analysis)

Last updated: July 8, 2026

Executive summary: International Isotopes (Intl Isotopes) is positioned as a radiopharmaceutical supply and isotope processing brand serving nuclear medicine and radiotherapy needs, with competitive pressure typically coming from isotope producers (reactor-based supply), radiopharmacy and contract manufacturing organizations, and downstream radiopharmaceutical developers that lock in supply through qualification, pricing, and quality agreements. A precise, litigation-grade patent estate comparison and Orange Book/FDA exclusivity mapping cannot be produced because no specific FDA-listed drug product identifiers, active ingredients, dosage forms, relevant filings, or named patent assignees for “intl isotopes” were provided.

No complete and accurate patent-to-product competitive landscape can be generated under the constraints.

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.